Case File
efta-efta01049971DOJ Data Set 9OtherDS9 Document EFTA01049971
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta01049971
Pages
1
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From•
To: Jeffrey Epstein <[email protected]>
Subject: aggregation and degeneration
Date: Mon, 10 Apr 2017 23:41:29 +0000
I think these all have a more common origin than we thought...involves vagus and stress
to the system. Different stressors hit different parts of the system. More when I see you.
The approach to prevent and treat would be radically different from what is happening
now.
Neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD),
amyotrophic lateral sclerosis (ALS) and prlon diseases are increasingly being realized to have common cellular and
molecular mechanisms including protein aggregation and inclusion body formation. The aggregates usually consist of
fibers containing misfolded protein with a
,eta-sheet conformation, termed amylold. There Is partial but not perfect
overlap among the cells in which abnormal proteins are deposited and the cells that degenerate. The most likely
explanation is that inclusions and other visible protein aggregates represent an end stage of a molecular cascade of
several steps, and that earlier steps in the cascade may be more directly tied to pathogenesis than the inclusions
themselves. For several diseases, genetic variants assist in explaining the pathogenesis of the more common sporadic
forms and developing mouse and other models. There is now increased understanding of the pathways Involved in
protein aggregation, and some recent clues have emerged as to the molecular mechanisms of cellular toxicity. These
are leading to approaches toward rational therapeutics.
EFTA01049971
Technical Artifacts (1)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
OtherUnknown
FEDWIRE PAYMENT DEBIT ADVICE
DOJ EFTA Data Set 10 document EFTA01273102
16p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.